Daniela Pachito: Honored to Present Four Research Posters at ISPOR 2026
Daniela Pachito, HEOR Manager at Pfizer, shared a post on LinkedIn:
“ISPOR 2026 has come to the end. It was a fantastic conference that heavily focused on how HEOR may help shape health systems around the globe and especially on the exciting opportunities that the responsible use of AI brings to the HEOR field.
I was pleased to present four posters – one addressing AI as a tool to identify treatment patterns and resource utilization in the context of multiple myeloma in real time, which was rated among the top 5% research posters!
Also very delighted to meet old friends and to get to know – or to meet in person for the first time – some brilliant colleagues.
A special heartfelt thank you to all coauthors, including Eduardo Röcker Ramos, Marcelo Dallagassa, Alana Vicente, Celina Borges Migliavaca, Maicon Falavigna, Ashley Cha-Silva, Camilla De Gaspari, Paulo Henrique Ribeiro Fernandes Almeida, Ana Carolina Dantas, Mariana Rezende Alves, Ana Karolina Santana Nunes, among others, to Mariana Mioti Sebastião for being such a good trip companion and to Rodrigo Fernandes Alexandre and Marcio Fontão dos Reis who relentlessly incentivize evidence generation and health economics analysis as a way of leveraging access to treatments for those in need and to promote sustainability of the health system.”
Ana Karolina Santana Nunes, Manager Medical Science Liaison at Pfizer, shared a post on LinkedIn:
“Honored to have contributed as a co-author to this work presented at ISPOR 2026.
Participating in initiatives that bring together science, evidence generation, and multidisciplinary collaboration reinforces my commitment to advancing care in hemophilia and rare diseases.
I am grateful to my colleagues and co-authors for their partnership and for the opportunity to contribute to knowledge generation with the potential to impact patients and healthcare systems.”
Stay updated with Hemostasis Today.
-
Jul 28, 2026, 07:50Mihail Celeski: Personalizing Anticoagulant Therapy for Frail Patients With Atrial Fibrillation
-
Jul 28, 2026, 07:36Ifeanyichukwu Ifechidere: What If the Test We’ve Trusted for Decades Has Been Telling Us Half the Story?
-
Jul 28, 2026, 07:10Wolfgang Miesbach: How Safe Is AAV Gene Therapy?
-
Jul 28, 2026, 06:59Fiona Robinson: New MASAC Recommendations for Iron Deficiency – Live Webinar
-
Jul 28, 2026, 06:49Vera Ghali: What Else Do Platelets Do Besides Clotting?
-
Jul 28, 2026, 02:54Joseph R. Shaw: Why Stroke Occurs Despite Anticoagulation
-
Jul 28, 2026, 02:45Are VWD Clinical Trials Missing What Matters Most to Women? – RPTH
-
Jul 28, 2026, 02:38Umberto Pensato: New BMJ Review on Breakthrough Stroke in Patients Receiving DOACs Is Now Live
-
Jul 27, 2026, 17:29Muhammad Numan: Normal MCV Does Not Exclude B12 Deficiency